Effect of maternal body mass index on in vitro response to tocolytics in term myometrium

Giuseppe Chiossi, Maged M. Costantine, Ancizar Betancourt, Gary D.V. Hankins, Monica Longo, George R. Saade, Egle Bytautiene

Producción científica: Articlerevisión exhaustiva

6 Citas (Scopus)


Objective: We sought to investigate the effect of body mass index (BMI) on in vitro response to tocolytics. Study Design: Myometrial biopsies were obtained at the time of scheduled cesarean deliveries from term nonlaboring women with BMI ≤29.9 (26.3 ± 1.3; n = 7), 30-34.9 (31.8 ± 1.2; n = 16), and ≥35 (39.5 ± 4.9; n = 9). Tissue strips were suspended in organ chambers for isometric tension recording. The effects of cumulative doses (10-10 to 10-5 mol/L) of nifedipine or indomethacin on spontaneous uterine contractility were determined. Areas under the contraction curve were compared using 1-way analysis of variance with Tukey post hoc test. Results: Myometrial response to tocolytics did not differ between the BMI groups. Nifedipine, but not indomethacin, significantly inhibited myometrial contractility independent of BMI. Conclusion: BMI does not affect uterine response to tocolytics in isolated uterine tissue from term nonlaboring women.

Idioma originalEnglish (US)
Páginas (desde-hasta)261.e1-261.e5
PublicaciónAmerican Journal of Obstetrics and Gynecology
EstadoPublished - sept 2010

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Profundice en los temas de investigación de 'Effect of maternal body mass index on in vitro response to tocolytics in term myometrium'. En conjunto forman una huella única.

Citar esto